Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement

Episode 3

0:00-15:28

We talk with Dr. Opeyemi Olabisi, MD, PhD, about the history and future of APOL1-mediated FSGS, the role of clinical researchers in building trust with patients, his innovative CARE and JUSTICE programs to bring kidney health screenings and research opportunities to the underrepresented African American community, and why his expertise as an MD/PhD in molecular biology led him to also become a leader in community engagement. The JAK-STAT pathway gets some love as well! Dr. Olabisi's research and publications: https://medicine.duke.edu/profile/opeyemi-olabisi More information on the CARE and JUSTICE studies: https://kidneycareandjustice.com/ Disclosures: Dr. Olabisi reports receiving research funding from NIH and Icagen, and consulting for Maze Therapeutics and Podium Bio.

Publisher

GN in Ten

Link

share.transistor.fm/s/5699c06f

Published

January 11, 2024

Duration

15 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

International Society of Glomerular Disease

GI

GN in Ten

@gninten

#opeyemiolabisi #mediatedkidneydisease #communityengagement #medicine #lifesciences

The Nile